Impact of adjuvant radiation on survival: A note of caution when using cancer registry data to evaluate adjuvant treatments

Annals of Surgical Oncology

Volumn 14, Issue 12, 2007, Pages 3321-3327

  Bilimoria, Karl Y ^a,b   Stewart, Andrew K ^b   Tomlinson, James S ^c   Gay, E Greer ^b   Ko, Clifford Y ^b,c   Talamonti, Mark S ^a   Bentrem, David J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Cancer Programs   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvant therapy; Chemoradiation; Chemotherapy; National Cancer Data Base; Radiation; SEER; Survival

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PANCREAS CANCER; PROPORTIONAL HAZARDS MODEL; RECTUM CANCER; RISK REDUCTION; STOMACH CANCER;

AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; NEOPLASMS; RADIOTHERAPY, ADJUVANT; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 36349035413     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9576-4     Document Type: Article

References (27)

1. National Cancer Institute: SEER Surveillance Epidemiology and End Results. Available: http://www.seer.cancer.gov / [accessed January 26, 2007]
2. The SEER Program Code Manual, revised. 3rd ed. Bethesda, MD: National Cancer Institute 1998
3. Standards for Cancer Registries. Volume II, Data Standards and Data Dictionary. 8th (10.1) ed., Bethesda, MD: National Cancer Institute 2003
4. Al-Refaie W, Pisters P, Chang G. Gastric adenocarcinoma in young patients: a population-based appraisal. American Society of Clinical Oncology: Gastrointestinal Cancers Symposium. Orlando, FL, 2007
5. Castalado E, Greco J, Feurer I, et al. Adjuvant radiation improves survival for surgically resected gastric adenocarcinoma. American Society of Clinical Oncology: Gastrointestinal Cancers Symposium (plenary presentation). Orlando, FL, 2007
6. Castalado E, Pinson C, Feurer I, Merchant N. Response to neoadjuvant radiation therapy for rectal cancer improves survival. American College of Surgeons Clinical Congress. Chicago, IL, 2006
7. Greco J, Castalado E, Feurer I, et al. Survival benefit with adjuvant radiation therapy in surgically resected pancreatic cancer. American Society of Clinical Oncology: Gastrointestinal Cancers Symposium (plenary presentation). Orlando, FL, 2007
8. Hazard L. Radiation Increases Survival in Select Pancreatic Cancer Patients. American Society of Therapeutic Radiation and Oncology Annual Meeting. Philadelphia, PA, 2006
9. Kiran RP, Pokala N, Dudrick SJ. Incidence pattern, survival for gallbladder cancer over three decades-an analysis of 10301 patients. Ann Surg Oncol 2007; 14(2):827-32
10. Vinh-Hung V, Burzykowski T, Van de Steene J, et al. Post-surgery radiation in early breast cancer: survival analysis of registry data. Radiother Oncol 2002; 64(3):281-90
11. Vinh-Hung V, Voordeckers M, Van de Steene J, et al. Omission of radiotherapy after breast-conserving surgery: survival impact and time trends. Radiother Oncol 2003; 67(2):147-58
12. Johnstone PA, Assikis V, Goodman M, et al. Lack of survival benefit of post-operative radiation therapy in prostate cancer patients with positive lymph nodes. Prostate Cancer Prostatic Dis 2007
13. Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol 2007; 25(9):1043-7
14. Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol 2004; 85(1):1-3
15. American Cancer Society, Cancer Facts and Figures. Available: http://www.cancer.org/docroot/STT/content/STT_1x_Cancer_Facts__Figures_2007.asp [accessed January 21, 2007]
16. International Classification of Disease for Oncology. 3rd ed. Geneva: World Health Organization, 2000
17. Standards of the Commission on Cancer, Volume II, Registry Operations and Data Standards. Commission on Cancer, 1998
18. Cox D. Regression models and life tables. J R Stat Soc 1972; 34(2):187-220
19. United States Census Bureau. Census 2000. Available: http://www.census. gov/main/www/cen2000.html [accessed January 21, 2007]
20. Lazovich D, Solomon CC, Thomas DB, et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 1999; 86(4):628-37
21. Keedy VL, Berlin J. Adjuvant and neoadjuvant approaches to treat surgically resectable pancreatic cancer. Curr Treat Options Oncol 2006; 7(5):381-8
22. Cancer Incidence-Surveillance, Epidemiology, and End Results (SEER) Registries Limited-Use. Available: http://seer.cancer.gov/data/metadata.html [accessed May 2, 2007]
23. Cress RD, Zaslavsky AM, West DW, et al. Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries. Med Care 2003; 41(9):1006-12
24. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003; 21(7):1293-300
25. Du XL, Key CR, Dickie L, et al. Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews. J Clin Epidemiol 2006; 59(1):53-60
26. Virnig BA, Warren JL, Cooper GS, et al. Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002; 40(8 Suppl):IV-49-54
27. SEER Surveillance Epidemiology and End Results: SEER-Medicare. Available: http://healthservices.cancer.gov/seermedicare / [accessed January 26, 2007]